ICU Medical (NASDAQ:ICUI) Lifted to Hold at BidaskClub

ICU Medical (NASDAQ:ICUI) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, BidAskClub reports.

Other research analysts have also recently issued reports about the company. Zacks Investment Research cut ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, June 3rd. Raymond James lifted their price objective on shares of ICU Medical from $215.00 to $228.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. CJS Securities raised shares of ICU Medical from a “market perform” rating to an “outperform” rating in a report on Tuesday, March 31st. KeyCorp reduced their target price on shares of ICU Medical from $206.00 to $199.00 and set an “overweight” rating for the company in a report on Wednesday, May 13th. Finally, ValuEngine lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Monday, April 27th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. ICU Medical presently has an average rating of “Hold” and an average target price of $211.67.

NASDAQ ICUI opened at $180.16 on Wednesday. The firm’s fifty day simple moving average is $187.62 and its two-hundred day simple moving average is $194.54. The firm has a market capitalization of $3.59 billion, a P/E ratio of 44.59 and a beta of 0.56. ICU Medical has a 12-month low of $148.89 and a 12-month high of $259.72.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.63 by $0.18. The business had revenue of $328.61 million during the quarter, compared to the consensus estimate of $302.97 million. ICU Medical had a return on equity of 10.45% and a net margin of 6.87%. The company’s quarterly revenue was down .7% on a year-over-year basis. During the same quarter last year, the company earned $2.58 earnings per share. On average, analysts forecast that ICU Medical will post 5.32 EPS for the current year.

In related news, Director George A. Lopez sold 10,000 shares of the stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $185.02, for a total value of $1,850,200.00. Following the completion of the transaction, the director now directly owns 340,964 shares of the company’s stock, valued at approximately $63,085,159.28. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director George A. Lopez sold 4,118 shares of the stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $200.29, for a total value of $824,794.22. Following the completion of the transaction, the director now directly owns 343,882 shares of the company’s stock, valued at $68,876,125.78. The disclosure for this sale can be found here. Insiders have sold 47,169 shares of company stock valued at $9,310,440 in the last three months. Corporate insiders own 10.90% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Synovus Financial Corp raised its holdings in shares of ICU Medical by 1,272.7% during the 1st quarter. Synovus Financial Corp now owns 151 shares of the medical instruments supplier’s stock worth $30,000 after acquiring an additional 140 shares during the period. Banque Cantonale Vaudoise acquired a new position in ICU Medical in the 4th quarter valued at about $35,000. Americana Partners LLC purchased a new stake in shares of ICU Medical in the 4th quarter valued at approximately $39,000. Arden Trust Co purchased a new stake in shares of ICU Medical in the 1st quarter valued at approximately $64,000. Finally, Signaturefd LLC increased its holdings in shares of ICU Medical by 38.5% during the 1st quarter. Signaturefd LLC now owns 360 shares of the medical instruments supplier’s stock worth $73,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 93.25% of the company’s stock.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

See Also: Find a Trading Strategy That Works

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.